CTRI/2024/01/061244
Not yet recruiting
未知
Prognostic impact of mutational analysis and it’s therapeutic implications in Gastrointestinal Stromal Tumours (GIST) - NI
Dr Antara Sanyal0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C189- Malignant neoplasm of colon, unspecifiedHealth Condition 2: C19- Malignant neoplasm of rectosigmoidjunctionHealth Condition 3: C20- Malignant neoplasm of rectumHealth Condition 4: C179- Malignant neoplasm of small intestine, unspecifiedHealth Condition 5: C169- Malignant neoplasm of stomach, unspecified
- Sponsor
- Dr Antara Sanyal
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Newly diagnosed case of GIST
- •2 Treatment naïve
- •Diagnosis will be based upon the morphology and immunophenotype of the primary followed by mutational analysis
Exclusion Criteria
- •1 Consent refusal
- •2 Patients with inadequate sample in tissue biopsy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Observational study on gene mutation and prognosis for patients with resectable pancreatic cancerpancreatic cancerJPRN-UMIN000032917Kobe university219
Recruiting
Not Applicable
Signification of gene mutational analysis using thyroid biopsy specimensPatients with thyroid tumorJPRN-UMIN000036208Institute of Biomedical Research,Sapporo Higashi Tokushukai Hospital100
Active, not recruiting
Not Applicable
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.EUCTR2010-021120-96-GBRoche Products Limited1,200
Completed
Not Applicable
Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents.lung cancerNon-small-cell lung cancer1002765610029107NL-OMON47255Sint Antonius Ziekenhuis350
Recruiting
Not Applicable
Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents.SCLCNiet-kleincellig longcarcinoomToxicityToxiciteitPlatinum agentsPlatinumhoudende chemotherapieNL-OMON27534St Antonius Ziekenhuis350